Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

E Fred Cohen


  • Director at Veracyte Inc. (VCYT), 2019-08-05
  • Director at Caredx Inc. (CDNA), 2019-07-15
  • Director at Genomic Health Inc (GHDX), 2019-07-03
  • Director at Urogen Pharma Ltd. (URGN), 2019-06-05
  • Director at Intellia Therapeutics Inc. (NTLA), 2019-05-22
  • Director at Tandem Diabetes Care Inc (TNDM), 2018-11-19
  • Director at Biocryst Pharmaceuticals Inc (BCRX), 2018-06-22
  • Director at Roka Bioscience Inc. (ROKA), 2017-06-30
  • Director at Five Prime Therapeutics Inc (FPRX), 2017-05-12
  • Director at Quintiles Transnational Holdings Inc. (Q), 2013-05-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GHDX $79.57 693 Director 67,619 2019-02-22 Filing
GHDX $78.80 9,307 Director 68,312 2019-02-22 Filing
GHDX $89.50 403 Director 67,464 2018-11-08 Filing
GHDX $88.73 4,200 Director 67,867 2018-11-08 Filing
GHDX $87.98 3,816 Director 72,067 2018-11-08 Filing